Loading...
Investigating barriers in HIV-testing oncology patients. The IBITOP study: phase I
BACKGROUND: Since the advent of combined antiretroviral therapy (ART), the incidence of non-AIDS-defining cancers (non-ADCs) among HIV-positive patients is rising. We previously described HIV testing rates of <5% in our oncology centre, against a local HIV prevalence of 0.4% [1]. We have since wo...
Na minha lista:
Udgivet i: | J Int AIDS Soc |
---|---|
Main Authors: | , , , , |
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
International AIDS Society
2014
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4224909/ https://ncbi.nlm.nih.gov/pubmed/25394126 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7448/IAS.17.4.19622 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|